XRpro Sciences is proud to re-launch Icagen as an expert provider of services for Ion Channel and Transporter drug discovery and development.

The “new” Icagen is being re-launched with the historic Icagen team and technological assets related to the ion channel biology platform acquired from Pfizer, Inc. (Read news release).

Icagen is bringing together the expertise of its scientific team in the ion channel field with its comprehensive portfolio of cell lines, assays and technologies and XRpro’s proprietary label-free technology for high throughput assessment of ion channels and transporters including challenging systems with high therapeutic interest, such as zinc transporters.  Our new website will be launching soon at www.icagen.com.

On the Scene

We will be presenting our advances in transporter research at the 2015 Ion Channel Retreat in Vancouver, on Tuesday, July 7.  Dr. Nathan Zahler will present results for zinc, phosphate and nonelectrogenic transporters.  Hope to see you there!

 

slas-logo

Nathan Zahler, Ph.D., Product Manager, will be presenting a poster entitled "Label-Free, High Throughput Ion Channel & Transporter Assays: Case Studies for TRPA1 & Nonelectrogenic Transporters" Poster number 1169 on Tuesday, Feb. 10 from 1-3pm

Request a copy of the poster

Debra Morgan, VP Corporate Development, will be presenting a poster entitled "High Performance, Label-Free Screening of Transporters and Ion Channels: X-ray Fluorescence for Challenging Assay" Poster number 1164 on Monday, Feb. 9 from 1-3pm

Request a copy of the poster

Explore the Advantages

To discuss how XRpro® can contribute to your drug discovery program, contact us today.

Broad Insitute Collaboration

We are proud to have a research collaboration with the Broad Institute of Harvard and MIT.